2020
DOI: 10.5599/admet.905
|View full text |Cite
|
Sign up to set email alerts
|

Metformin effects on zonulin level in polycystic ovarian women

Abstract: Zonulin protein is a haptoglobin precursor and functions to modulate the permeability of tight junctions between enterocytes. Local inflammation or systemic inflammation can trigger zonulin expression. While the increased zonulin level causes an increase of intestinal permeability and entrance of foreign antigens, the latter can increase insulin resistance and inflammation. Polycystic ovarian syndrome affects women during their reproductive age characterized by hyperinsulinemia and/or hyperandrogenemia and ass… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 46 publications
(42 reference statements)
0
1
0
Order By: Relevance
“…Additionally, the zonulin concentration values of 18 participants in this cohort were unintelligible, reducing the statistical power of this study. Considering that Metformin, a glucose-mediating medication used to manage type II diabetes, has been shown to augment intestinal microbial composition and T levels in women with PCOS, differences in the study population mean BMI (30.2 versus 25.6), and thereby glucose uptake and insulin-sensitivity (unmeasured in both studies), may further explain this discrepancy [66,67]. Supporting this notion of metabolic stress, namely inflammatory mechanical and metabolic stress-states occurring with high-intensity exercise and long periods of exercise, have been shown to increase intestinal permeability (as measured by zonulin) via alterations to intestinal microflora and reductions of gastrointestinal blood flow.…”
Section: Discussionmentioning
confidence: 90%
“…Additionally, the zonulin concentration values of 18 participants in this cohort were unintelligible, reducing the statistical power of this study. Considering that Metformin, a glucose-mediating medication used to manage type II diabetes, has been shown to augment intestinal microbial composition and T levels in women with PCOS, differences in the study population mean BMI (30.2 versus 25.6), and thereby glucose uptake and insulin-sensitivity (unmeasured in both studies), may further explain this discrepancy [66,67]. Supporting this notion of metabolic stress, namely inflammatory mechanical and metabolic stress-states occurring with high-intensity exercise and long periods of exercise, have been shown to increase intestinal permeability (as measured by zonulin) via alterations to intestinal microflora and reductions of gastrointestinal blood flow.…”
Section: Discussionmentioning
confidence: 90%